Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats

Abstract

Background. The obese Zucker rat exhibits insulin resistance, develops nephropathy at an early age, and may be a model of diabetic nephropathy. Dehydroepiandrosterone (DHEA) may ameliorate many of the factors that contribute to diabetic nephropathy, while angiotensin-converting enzyme inhibitors are known to be effective. One marker of nephropathy is the expression of α-smooth muscle actin. Methods. We studied the effect of DHEA on the expression of α-smooth muscle actin in obese Zucker rats and compared the changes with those in a control group, a group given quinapril, and a group on a low-calorie diet. DHEA (0.6%) added to plain chow, quinapril (0.3 mg/kg) added to drinking water, and a low-calorie diet based on pair-feeding were administered to obese rats from age 4 to 20 weeks. Immunohistochemical expression of α-smooth muscle actin, a marker of interstitial and glomerular fibrosis and an early indicator of nephropathy, was measured semiquantitatively in glomeruli, cortical interstitium, and medullary interstitium on a scale of 0 to 4 and was reported as mean ± SEM. Results. When compared with the obese control group, quinapril exhibited a marked reduction in α-smooth muscle actin staining in glomeruli, cortical interstitium, and medullary interstitium (P < 0.0005); DHEA reduced α-smooth muscle actin staining in cortical interstitium and medullary interstitium (P < 0.005), and a low-calorie diet reduced α-smooth muscle actin staining in cortical and medullary interstitium (P < 0.005), which was similar to the effects of DHEA. Conclusions. DHEA was similar to a low-calorie diet in reducing the immunohistochemical staining of α-smooth muscle actin in obese Zucker rats. However, quinapril exerted a marked protective effect on the development of fibrosis, as indicated by α-smooth muscle actin staining, which was significantly less than that of DHEA at the doses studied.